Lehot J J, Bastien O, Girard C, Ruynat L, Tartulier M
Cah Anesthesiol. 1985 Apr-May;33(3):239-47.
Since the synthesis of Fentanyl in 1961, many narcotics have appeared which are not yet available in France. Among agonists, all are Fentanyl derivates but are different by either more powerful (sufentanyl, lofentanyl), and longer-acting effects (lofentanyl), or less powerful and shorter-acting effects (alfentanyl). All would have a greater security index and minimal cardiovascular side effects. Among agonists-antagonists, only pentazocine is available in France for analgesic therapy. The interest of other new molecules as butorphenol, nalbuphine and buprenorphine, which are available in other countries, still remains a matter of discussion.
自1961年芬太尼合成以来,出现了许多在法国尚未上市的麻醉药品。在激动剂中,所有都是芬太尼衍生物,但不同之处在于要么作用更强(舒芬太尼、洛芬太尼)、作用时间更长(洛芬太尼),要么作用较弱、作用时间较短(阿芬太尼)。所有这些药物都可能具有更高的安全指数和最小的心血管副作用。在激动剂-拮抗剂中,法国仅将喷他佐辛用于镇痛治疗。其他国家可用的其他新分子如布托啡诺、纳布啡和丁丙诺啡的优势仍有待讨论。